ProCE Banner Activity

DAA Treatment for HCV Reduced Healthcare Service Utilization in a Population of Individuals With HIV/HCV Coinfection in Canada

Slideset Download
Conference Coverage
Reduced inpatient and outpatient visits observed following SVR with oral HCV DAA therapy in real-world HIV/HCV-coinfected population.

Released: March 17, 2020

Expiration: March 16, 2021

No longer available for credit.

Share

Provided by

Provided by the USF Health
ProCE Banner

Supporters

This activity is supported by educational grants from

Gilead

Merck & Co., Inc.

ViiV Healthcare